Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
Hexcel
HXL
$7.17B
| $4.5M | 0.01% |
+61,400
| New | +$4.72M |
|
2002
Precigen
PGEN
$2.49B
| $4.5M | 0.01% |
820,883
+655,535
| +396% | +$3.69M |
|
2003
Cardlytics
CDLX
$23.7M
| $4.48M | 0.01% |
7,130
-11,641
| -62% | -$5.69M |
|
|
DNR
2004
DELISTED
Denbury Resources, Inc.
DNR
| $4.48M | 0.01% |
3,176,083
-3,490,092
| -52% | -$3.89M |
|
2005
PUT
Dollar Tree
DLTR
$24.1B
| $4.48M | 0.01% |
47,600
-16,200
| -25% | -$1.7M |
|
2006
Brunswick
BC
$4.97B
| $4.46M | 0.01% |
74,315
+25,571
| +52% | +$1.48M |
|
2007
iShares MSCI Australia ETF
EWA
$1.34B
| $4.45M | 0.01% |
+196,482
| New | +$4.42M |
|
|
GTHX
2008
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $4.44M | 0.01% |
168,054
-118,700
| -41% | -$2.78M |
|
|
BRSL
2009
Brightstar Lottery PLC
BRSL
$2.11B
| $4.44M | 0.01% |
+296,462
| New | +$4.22M |
|
2010
BellRing Brands
BRBR
$1.24B
| $4.43M | 0.01% |
+208,333
| New | +$4.08M |
|
2011
Parker-Hannifin
PH
$125B
| $4.42M | 0.01% |
21,492
-146,199
| -87% | -$28.3M |
|
|
BCOV
2012
DELISTED
Brightcove, Inc.
BCOV
| $4.42M | 0.01% |
508,619
+111,269
| +28% | +$1.04M |
|
|
RIDE
2013
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $4.42M | 0.01% |
+29,587
| New | +$4.4M |
|
2014
Oneok
OKE
$59.7B
| $4.41M | 0.01% |
58,312
-509,058
| -90% | -$36.4M |
|
|
BLUE
2015
CALL
DELISTED
bluebird bio
BLUE
| $4.39M | 0.01% |
3,860
+1,544
| +67% | +$1.68M |
|
2016
Upland Software
UPLD
$13.9M
| $4.38M | 0.01% |
12,271
+2,609
| +27% | +$975K |
|
|
TARO
2017
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $4.38M | 0.01% |
49,833
-32,558
| -40% | -$2.75M |
|
2018
Criteo S.A.
CRTO
$855M
| $4.38M | 0.01% |
252,473
-361,936
| -59% | -$6.44M |
|
|
CSII
2019
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.37M | 0.01% |
90,000
+5,000
| +6% | +$228K |
|
|
LTM
2020
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $4.37M | 0.01% |
430,191
+13,676
| +3% | +$153K |
|
|
CURO
2021
DELISTED
CURO Group Holdings Corp.
CURO
| $4.37M | 0.01% |
358,394
-162,057
| -31% | -$2.17M |
|
2022
Corvus Pharmaceuticals
CRVS
$1.19B
| $4.35M | 0.01% |
799,830
-152,367
| -16% | -$533K |
|
|
CFFAU
2023
DELISTED
CF Finance Acquisition Corp. Unit
CFFAU
| $4.34M | 0.01% |
400,000
| – | – |
|
|
TLND
2024
DELISTED
Talend S.A. American Depositary Shares
TLND
| $4.33M | 0.01% |
110,853
-44,145
| -28% | -$1.63M |
|
|
2025
Hexcel
HXL
$7.17B
| $4.33M | 0.01% |
59,003
-232,226
| -80% | -$17.8M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.